Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at ginisortamab for pancreatic cancer that has spread

Overview

Cancer types:

Pancreatic cancer, Secondary cancers

Status:

Open

Phase:

Phase 2

Details

This trial is looking at adding a new drug called ginisortamab to chemotherapy for pancreatic cancer that has spread to other parts of the body. Cancer that has spread is advanced or metastatic cancer.

It is for people who haven’t yet had treatment for advanced pancreatic cancer.

You pronounce ginisortamab as gin-ee-saw-ta-mab.

Cancer Research UK supports this trial.

Recruitment start: 23 April 2024

Recruitment end: 31 July 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jeff Evans

Supported by

Cancer Research UK (Centre for Drug Development)

UCB Biopharma SRL

Other information

This is Cancer Research UK trial number CRUKD/24/002.

Last reviewed: 29 April 2025

CRUK internal database number: 19221

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.